Approval · Notice of Compliance 13540 · 2012
ALLERTIN: Notice of Compliance 13540
Issued August 1, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13540
- Date
- August 1, 2012
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Labelling Only
- Therapeutic class
- Antihistamine
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ALLERTIN | 02390388 | Marketed |
Medicinal ingredients
- LORATADINE 10 MG per CAP